Literature DB >> 30354848

Anatomical Predictors of Endoleaks or Migration After Endovascular Aneurysm Sealing.

Kim van Noort1,2, Johannes T Boersen1,2, Aleksandra C Zoethout3,4, Richte C L Schuurmann1,2, Jan M M Heyligers5, Michel M P J Reijnen3, Clark J Zeebregts4, Cornelis H Slump2, Jean-Paul P M de Vries1,4.   

Abstract

PURPOSE: To identify preoperative anatomical aortic characteristics that predict seal failures after endovascular aneurysm sealing (EVAS) and compare the incidence of events experienced by patients treated within vs outside the instructions for use (IFU).
METHODS: Of 355 patients treated with the Nellix EndoVascular Aneurysm Sealing System (generation 3SQ+) at 3 high-volume centers from March 2013 to December 2015, 94 patients were excluded, leaving 261 patients (mean age 76±8 years; 229 men) for regression analysis. Of these, 83 (31.8%) suffered one or more of the following events: distal migration ⩾5 mm of one or both stent frames, any endoleak, and/or aneurysm growth >5 mm. Anatomical characteristics were determined on preoperative computed tomography (CT) scans. Patients were divided into 3 groups: treated within the original IFU (n=166), outside the original IFU (n=95), and within the 2016 revised IFU (n=46). Categorical data are presented as the median (interquartile range Q1, Q3).
RESULTS: Neck diameter was significantly larger in the any-event cohort vs the control cohort [23.7 mm (21.7, 26.3) vs 23.0 mm (20.9, 25.2) mm, p=0.022]. Neck length was significantly shorter in the any-event cohort [15.0 mm (10.0, 22.5) vs 19.0 mm (10.0, 21.8), p=0.006]. Maximum abdominal aortic aneurysm (AAA) diameter and the ratio between the maximum AAA diameter and lumen diameter in the any-event group were significantly larger than the control group (p=0.041 and p=0.002, respectively). Regression analysis showed aortic neck diameter (p=0.006), neck length (p=0.001), and the diameter ratio (p=0.011) as significant predictors of any event. In the comparison of events to IFU status, 52 (31.3%) of 166 patients in the inside the original IFU group suffered an event compared to 13 (28.3%) of 46 patients inside the 2016 IFU group (p=0.690).
CONCLUSION: Large neck diameter, short aortic neck length, and the ratio between the maximum AAA and lumen diameters are preoperative anatomical predictors of the occurrence of migration (⩾5 mm), any endoleak, and/or aneurysm growth (>5 mm) after EVAS. Even under the refined 2016 IFU, more than a quarter of patients suffered from an event. Improvements in the device seem to be necessary before this technique can be implemented on a large scale in endovascular AAA repair.

Entities:  

Keywords:  abdominal aortic aneurysm; aneurysm growth; endograft; endoleak; endovascular aneurysm repair; endovascular aneurysm sealing; instructions for use; migration

Mesh:

Year:  2018        PMID: 30354848     DOI: 10.1177/1526602818808296

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  3 in total

1.  Secondary Fill Minimizes Gutter Size in Chimney EVAS Configurations In Vitro.

Authors:  Theodorus G van Schaik; Jorn P Meekel; Vincent Jongkind; Rutger J Lely; Maarten Truijers; Arjan W J Hoksbergen; Willem Wisselink; Jan D Blankensteijn; Kak Khee Yeung
Journal:  J Endovasc Ther       Date:  2018-12-21       Impact factor: 3.487

2.  Systematic Review on the Mid-Term Outcomes of Elective Endovascular Aneurysm Sealing in Comparison to Endovascular Aneurysm Repair.

Authors:  Aleksandra C Zoethout; Iris Hochstenbach; Maarten J van der Laan; Jean-Paul P M de Vries; Michel M P J Reijnen; Clark J Zeebregts
Journal:  J Endovasc Ther       Date:  2021-09-27       Impact factor: 3.089

3.  An International, Multicenter Retrospective Observational Study to Assess Technical Success and Clinical Outcomes of Patients Treated with an Endovascular Aneurysm Sealing Device for Type III Endoleak.

Authors:  Aleksandra C Zoethout; Shirley Ketting; Clark J Zeebregts; Dimitri Apostolou; Barend M E Mees; Patrick Berg; Hazem El Beyrouti; Jean-Paul P M De Vries; Francesco Torella; Mattia Migliari; Roberto Silingardi; Michel M P J Reijnen
Journal:  J Endovasc Ther       Date:  2021-08-03       Impact factor: 3.487

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.